Section R9-6-352. Meningococcal Invasive Disease

A.      Case control measures:

1.        A diagnosing health care provider or an administrator of a health care institution, either personally or through a rep- resentative, shall isolate and institute droplet precautions for a meningococcal invasive disease case for 24 hours after the initiation of treatment.

2.        A local health agency shall:

a.        Upon receiving a report under R9-6-202 or R9-6- 203 of a meningococcal invasive disease case or sus- pect case, notify the Department within 24 hours after receiving the report and provide to the Depart- ment the information contained in the report;

b.        Conduct an epidemiologic investigation of each reported meningococcal invasive disease case or suspect case;

c.        For each meningococcal invasive disease case, sub- mit to the Department, as specified in Article 2, Table 4, the information required under R9-6- 206(D); and

d.        Ensure that an isolate from each meningococcal invasive disease case is submitted to the Arizona State Laboratory.

B.       Contact control measures: A local health agency shall evaluate the level of risk of transmission from each contact’s exposure to a meningococcal invasive disease case and, if indicated, provide or arrange for each contact to receive prophylaxis.

Historical Note

Renumbered from R9-6-745 and amended effective Octo- ber 19, 1993 (Supp. 93-4). Former Section R9-6-352 renumbered to R9-6-355; new Section R9-6-352 renum- bered from R9-6-349 effective April 4, 1997 (Supp. 97-2).

Former R9-6-352 renumbered to R9-6-360; new R9-6- 352 renumbered from R9-6-344 and amended by final rulemaking at 10 A.A.R. 3559, effective October 2, 2004 (Supp. 04-3). Former R9-6-352 renumbered to R9-6-357; new R9-6-352 renumbered from R9-6-348 and amended by final rulemaking at 14 A.A.R. 1502, effective April 1, 2008 (Supp. 08-2).